Interleukin levels and depressive symptoms in psoriatic arthritis patients: insights from a case–control study on socio-demographic factors and disease perception-Reference-Cited by-同舟云学术

Interleukin levels and depressive symptoms in psoriatic arthritis patients: insights from a case–control study on socio-demographic factors and disease perception

Published:2024-05-10 Issue:7 Volume:44 Page:1337-1343
ISSN:1437-160X
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Waszczak-Jeka Marzena^ORCID,Żuchowski Paweł^ORCID,Dura Marta^ORCID,Bielewicz-Zielińska Agnieszka^ORCID,Kułakowski Michał^ORCID,Góralczyk Alicja^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00296-024-05599-0.pdf

Reference28 articles.

1. Lee BW, Moon SJ (2023) Inflammatory cytokines in psoriatic arthritis: understanding pathogenesis and implications for treatment. Int J Mol Sci 24(14):11662. https://doi.org/10.3390/ijms241411662

2. Żuchowski P, Dura M, Kaźmierczak K et al (2023) Comparison of advanced glycation end products concentration in the skin among patients with rheumatic diseases, with and without comorbid depression: a case-control study. Rheumatol Int 43(10):1829–1834. https://doi.org/10.1007/s00296-023-05393-4

3. Gupta S, Syrimi Z, Hughes DM et al (2021) Comorbidities in psoriatic arthritis: a systematic review and meta-analysis. Rheumatol Int 41(2):275–284. https://doi.org/10.1007/s00296-020-04775-2

4. Panagiotopoulos A, Fragoulis GE (2023) Comorbidities in psoriatic arthritis: a narrative review. Clin Ther 45(2):177–189. https://doi.org/10.1016/j.clinthera.2023.01.006

5. Mathew AJ, Chandran V (2020) Depression in psoriatic arthritis: dimensional aspects and link with systemic inflammation. Rheumatol Ther 7(2):287–300. https://doi.org/10.1007/s40744-020-00207-